Liberant thrombectomy system case survey
Part of Heart & circulation clinical trials.
This survey collects feedback from doctors who used the Liberant system to remove blood clots. The results help understand how well the device works in real-life procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were at least 22 years old when the procedure was done
- The Liberant device was used as directed by the manufacturer
- The procedure happened within 72 hours of using the device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how well the Cleaner Vac® system works to remove blood clots from leg veins over time. It may be an option for people with new or recent deep vein thrombosis (DVT) who are getting their first treatment.
This study tests a device that vacuums out blood clots from blocked leg arteries, potentially restoring blood flow without open surgery.
This study tests a device called JETi® that uses a tiny jet of fluid to break up and remove blood clots in leg arteries. It may help people with sudden or recent leg artery blockages improve blood flow and avoid more serious complications.
This trial tests how safe and effective a clot-removal procedure done through the blood vessels is for people with acute or subacute blocked blood flow in the lower leg. It may help by improving circulation while carefully tracking risks and results.
This study tests a device that removes blood clots from the deep veins of your leg. It's designed to help people with recent or slightly older clots in the thigh or pelvic area, aiming to reduce symptoms and prevent complications.
This trial compares different mechanical devices used to remove recent blood clots from the deep veins in your leg (iliac and femoral veins). The goal is to restore blood flow and prevent long-term complications like chronic pain and swelling.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.